Literature DB >> 32332303

Pearls and Pitfalls in Interpretation of 68Ga-DOTATOC PET Imaging.

Asma Bashir1, Helle Broholm2, Erik Clasen-Linde2, Mark B Vestergaard1, Ian Law1.   

Abstract

DOTA-D-Phe-Tyr-octreotide labeled with Ga (Ga-DOTATOC) is the commonly used PET tracer for imaging meningioma because of its high affinity to somatostatin receptor subtype 2 (SSTR2) and an established imaging modality for planning radiation and radionuclide therapy. However, SSTR2 is not an exclusive marker for meningioma, and not all meningiomas express high levels of SSTR2. The SSTR2 expression has been reported in other intracranial tumors, for example, glioma, pituitary adenoma, medullablastoma, primitive neuroectodermal tumors, and hemangioblastoma leading to a significant risk of misinterpretation of PET/CT findings. We present 2 cases with similar Ga-DOTATOC uptakes in 2 distinct etiologies, for example, cerebral lymphoma and meningioma.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32332303     DOI: 10.1097/RLU.0000000000003012

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

Review 1.  The Role of [68Ga]Ga-DOTA-SSTR PET Radiotracers in Brain Tumors: A Systematic Review of the Literature and Ongoing Clinical Trials.

Authors:  Paolo Palmisciano; Gina Watanabe; Andie Conching; Christian Ogasawara; Gianluca Ferini; Othman Bin-Alamer; Ali S Haider; Maria Gabriella Sabini; Giacomo Cuttone; Sebastiano Cosentino; Massimo Ippolito; Giuseppe E Umana
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

Review 2.  Prevalence and significance of incidental findings on 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET/CT: a systematic review of the literature.

Authors:  Morten Bentestuen; Farid Gossili; Charlotte Elberling Almasi; Helle Damgaard Zacho
Journal:  Cancer Imaging       Date:  2022-09-03       Impact factor: 5.605

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.